Halozyme Therapeutics, Inc. - Common Stock (HALO)

Halozyme Therapeutics is a biotechnology company that focuses on the development and commercialization of novel therapeutics for the treatment of various diseases, particularly in oncology and chronic diseases

The company specializes in its proprietary proprietary enzyme technology, which enhances the delivery and effectiveness of therapeutics, including biologics and monoclonal antibodies. Halozyme collaborates with other pharmaceutical companies to improve their drug formulations and patient delivery systems, ultimately aiming to provide innovative solutions that enhance treatment outcomes for patients.